Published in
American Society of Hematology, Blood, 16(131), p. 1820-1832
DOI: 10.1182/blood-2017-11-817296
Links
Tools
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide
Journal article published in 2018 by
Koichi Takahashi 
,
Boyu Hu,
Feng Wang,
Yuanqing Yan,
Ekaterina Kim,
Candida Vitale ,
Keyur P. Patel,
Paolo Strati,
Curtis Gumbs,
Latasha Little,
Samantha Tippen,
Xingzhi Song,
Jianhua Zhang,
Nitin Jain,
Philip Thompson
and other authors.
,
Boyu Hu,
Feng Wang,
Yuanqing Yan,
Ekaterina Kim,
Candida Vitale ,
Keyur P. Patel,
Paolo Strati,
Curtis Gumbs,
Latasha Little,
Samantha Tippen,
Xingzhi Song,
Jianhua Zhang,
Nitin Jain,
Philip Thompson
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Cancer gene mutations affect treatment response and survival in patients with CLL treated with lenalidomide. The assessment of cancer gene mutations may be useful in the risk stratification of CLL patients.